A comparative analysis of human bone marrow–resident and peripheral memory B cells - 04/05/18
Doi : 10.1016/j.jaci.2017.12.983
Sonya C. Becker, MSc a, ∗, Martin Szyska, PhD b, ∗, Angela Mensen, PhD a, ∗, Katharina Hellwig c, Raik Otto, MSc d, Lisa Olfe, MD a, e, Hans-Dieter Volk, MD a, f, Thomas Dörner, MD g, Bernd Dörken, MD e, Carmen Scheibenbogen, MD a, Jörg Schröder, MD h, Andreas C. Hocke, MD c, Il-Kang Na, MD b, e, f, i 
a Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
b Experimental and Clinical Research Center, Berlin, Germany
c Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
d Institute for Computer Sciences, Humboldt University Berlin, Berlin, Germany
e Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
f Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
g German Arthritis Research Center, Berlin, Germany
h Department of Accident and Reconstructive Surgery, Charité CVK, Berlin, Germany
i Berlin Institute of Health, Berlin, Germany
| This work was supported by the Else Kröner-Fresenius Foundation (grant no. EKFS 2013_A187), by the Berliner Krebsgesellschaft (grant no. LOPS201604 to L.O.), partly by the German Research Foundation (grant nos. DFG SFB-TR84, B6, and Z1a to A.C.H.), by the Bundesministerium für Bildung und Forschung (BMBF) (with the MAPTor-NET-demonstrator research grant 031A426C), by the Deutsche Forschungsgemeinschaft (DFG) (projects Do491/7-3,4 and Do491/8-1,2), by the Stiftung Charité, and by the Berlin Institute of Health (BIH). |
|
| Disclosure of potential conflict of interest: I.-K. Na received grants from the EKFS, Berliner Krebsgesellschaft, Stiftung Charité and the BIH for this work. R. Otto is employed by Humboldt-Universitaet zu Berlin - Institute of Mathematics and Computer Science, Charite University Hospital Berlin; and received payment for lectures from Humboldt-Universitaet zu Berlin - Institute of Mathematics and Computer Science. H.-D. Volk’s institution received grant Berlin Cardiovascular Research Institute (BCRI) from the German Federal Ministry of Education and Research. H.-D. Volk received grants from Berlin-Brandenburg Center for Regenerative Therapies (BCRT), DFG, EU-horizon 2020, and European Union Framework Programme 7 (EU-FP7) for other works; board membership from Tissuse and Labex; consultancy fees from Bayer, Charité Research Organisation (CRO), Baxalta/Shire, and Boehringer Ingelheim; royalties from 3 patents; and stock options from several companies. C. Scheibenbogen received consultancy fees from IgG therapy, Octapharma, and Vaccines Curevac; payment for lectures from Primary Immunodeficiency (PID); and travel expenses from European Society for Immunodeficiencies (ESID) and Octapharma. Her institution received grants from B cell differentiation common variable immunodeficiency (CVID) Octapharma and IgG therapy Shire for other works. A. C. Hocke's institution received grants DFG, SFB-TR84, B6,Z1a for this work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1911 - mai 2018 Retour au numéro
Article précédent
- Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory
- Jelle de Wit, Maarten E. Emmelot, Martien C.M. Poelen, Rob S. van Binnendijk, Saskia van der Lee, Debbie van Baarle, Wanda G.H. Han, Cécile A.C.M. van Els, Patricia Kaaijk
- Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy
- Melanie C. Dispenza, Jacqueline A. Pongracic, Anne M. Singh, Bruce S. Bochner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?